InvestorsHub Logo
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

Re: None

Thursday, 03/23/2017 1:19:16 PM

Thursday, March 23, 2017 1:19:16 PM

Post# of 144812
17 MAR 2017/ PharmaCyte Biotech CEO Addresses IND Submission Questions

LAGUNA HILLS, Calif., March 17, 2017 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today released a statement by Chief Executive Officer Kenneth L. Waggoner that addresses the company’s position on releasing a date for
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News